TNF and rheumatoid arthritis: Although anti-TNF-α drugs are available for inflammatory diseases such as rheumatoid arthritis, no treatment targeting TNF-α-induced signalling is available to mitigate endothelial pro-inflammatory activation in the postoperative context, blocking TNF-α-induced signalling completely, also in other cell types like macrophages in major surgery, is not seem desirable.